All therapeutic antibody articles
-
NewsSingle nanobody therapy targets three highly pathogenic human coronaviruses
Researchers have developed a bispecific nanobody that neutralised SARS-CoV, SARS-CoV-2 and MERS-CoV in laboratory tests. A single dose also reduced viral loads and protected mice from all three infections, pointing to a potential broad-spectrum treatment for current and future coronavirus threats.